USPTO serial 79435667
Reviewed by CopyMark Law Group
Status 700 means the trademark is registered and active on the Principal Register. You have nationwide rights for the listed goods and services and may use ®. Section 8 maintenance is due between years five and six. Calendar Section 8 between years five and six, and consider trademark monitoring.
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Rovi Pharma Industrial Services, S.A.
ES
Other trademarks owned by Rovi Pharma Industrial Services, S.A.
Rovi Pharma Industrial Services, S.A.
ES
Other trademarks owned by Rovi Pharma Industrial Services, S.A.
Rovi Pharma Industrial Services, S.A.
ES
Other trademarks owned by Rovi Pharma Industrial Services, S.A.
The USPTO lists this attorney as the applicant's representative for correspondence on this application.
Andrea L. Hintz
Andrea L. Hintz Resonate IP, LLCP.O. Box 1650Bend, OR 97709United States| Class | Description | Status | First use |
|---|---|---|---|
| 040 | Custom manufacturing of pharmaceuticals, preparations for medical and veterinary use in the nature of injectable pharmaceuticals, pharmaceuticals in solid forms, pre-filled water for injection (WFI) syringes, hygienic and sanitary products for medical use, dietetic food and supplements for medical or veterinary use, baby food, food supplements for humans or animals, plasters in the nature of adhesive bandages, medical dressing materials, dental filling and impression materials, disinfectants, surgical and medical devices, namely, pre-filled syringes and cartridges for use with injectable pharmaceutical products, artificial limbs, eyes and teeth, orthopedic devices and medical suture material; processing of chemical products, namely, chemical processing services; microencapsulating of pharmaceutical and medical preparations services provided for others; custom manufacturing of medical devices in the nature of surgical, medical, dental, and veterinary apparatus and instruments for third parties; custom manufacture of biopharmaceuticals | ACTIVE | — |
| 042 | Scientific and technological services, namely, scientific testing and analysis of pharmaceutical and medical preparations in the pharmaceutical field; scientific research and design services in the field of pharmaceutical products; scientific research in the field of pharmaceuticals; industrial analysis and industrial research in the field of pharmaceutical and medical preparations; design and development of computer hardware and software; research and development of new products for others; research regarding new pharmaceutical products; development of pharmaceutical products; bacteriological research; biological research; geological research; chemical research; technical research in the field of pharmaceutical studies; Technical research in the field of medical studies; conducting of feasibility studies in the field of pharmaceutical and medical preparations; quality control of goods and services; authentication services in the field of pharmaceutical and medical preparations; chemical analysis; medical research laboratory services; testing of new products for others; testing of chemicals; Scientific research in the nature of conducting clinical trials for others; consultancy in the field of pharmacology; quality control for manufactured goods; quality evaluation of pharmaceutical products. | ACTIVE | — |
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
| Date | Code | Event | What it means |
|---|---|---|---|
| Jul 28, 2026 | NRCC | NOTICE OF REGISTRATION CONFIRMATION EMAILED | — |
| Jul 28, 2026 | R.PR | REGISTERED-PRINCIPAL REGISTER | Your trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive. |
| Jun 9, 2026 | NPUB | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | — |
| Jun 9, 2026 | PUBO | PUBLISHED FOR OPPOSITION | Your mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance. |
| Jun 3, 2026 | NONP | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | — |
| May 15, 2026 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| May 11, 2026 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| May 11, 2026 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| May 11, 2026 | TROA | TEAS RESPONSE TO OFFICE ACTION RECEIVED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Feb 12, 2026 | RFNT | REFUSAL PROCESSED BY IB | — |
| Jan 25, 2026 | RFCS | NON-FINAL ACTION MAILED - REFUSAL SENT TO IB | — |
| Jan 24, 2026 | RFRR | REFUSAL PROCESSED BY MPU | — |
| Dec 23, 2025 | RFCR | NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW | — |
| Dec 22, 2025 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Dec 12, 2025 | DOCK | ASSIGNED TO EXAMINER | — |
| Nov 3, 2025 | MAFR | APPLICATION FILING RECEIPT MAILED | — |
| Nov 3, 2025 | NWOS | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | — |
| Oct 30, 2025 | REPR | SN ASSIGNED FOR SECT 66A APPL FROM IB | — |